ABCA1 Agonist Mimetic Peptide CS-6253 Induces Microparticles Release From Different Cell Types by ABCA1-Efflux–Dependent Mechanism

Bielicki, 2016, ABCA1 agonist peptides for the treatment of disease, Current opinion in lipidology. Curr Opin Lipidol, 27, 40, 10.1097/MOL.0000000000000258 Hafiane, 2015, Novel Apo E-derived ABCA1 agonist peptide (CS-6253) promotes reverse cholesterol transport and induces formation of prebeta-1 HDL in vitro, PloS One, 10, e0131997, 10.1371/journal.pone.0131997 Choi, 2017, High-density lipoproteins: biology, epidemiology, and clinical management, Can J Cardiol, 33, 325, 10.1016/j.cjca.2016.09.012 Hafiane, 2013, HDL, atherosclerosis, and emerging therapies, Cholesterol, 2013, 891403, 10.1155/2013/891403 Nandi, 2009, ABCA1-mediated cholesterol efflux generates microparticles in addition to HDL through processes governed by membrane rigidity, J Lipid Res, 50, 456, 10.1194/jlr.M800345-JLR200 Vaughan, 2003, ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions, J Lipid Res, 44, 1373, 10.1194/jlr.M300078-JLR200 Duong, 2006, Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I, J Lipid Res, 47, 832, 10.1194/jlr.M500531-JLR200 Hafiane, 2017, ATP binding cassette A1 (ABCA1) mediates microparticle formation during high-density lipoprotein (HDL) biogenesis, Atherosclerosis, 257, 90, 10.1016/j.atherosclerosis.2017.01.013 Choi, 2017, Desmocollin 1 is abundantly expressed in atherosclerosis and impairs high-density lipoprotein biogenesis, Eur Heart J, 39, 1194, 10.1093/eurheartj/ehx340 Qian, 2017, Structure of the human lipid exporter ABCA1, Cell, 169, 1228, 10.1016/j.cell.2017.05.020 Wang, 2014, ABCA1 and nascent HDL biogenesis, Biofactors, 40, 547, 10.1002/biof.1187 Iatan, 2011, Membrane microdomains modulate oligomeric ABCA1 function: impact on apoAI-mediated lipid removal and phosphatidylcholine biosynthesis, J Lipid Res, 52, 2043, 10.1194/jlr.M016196 Ma, 2011, Ht31, a protein kinase A anchoring inhibitor, induces robust cholesterol efflux and reverses macrophage foam cell formation through ATP-binding cassette transporter A1, J Biol Chem, 286, 3370, 10.1074/jbc.M110.173666 Remaley, 2003, Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway, J Lipid Res, 44, 828, 10.1194/jlr.M200475-JLR200 Amar, 2010, 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice, J Pharmacol Exp Ther, 334, 634, 10.1124/jpet.110.167890 Oram, 2001, ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol, J Biol Chem, 276, 39898, 10.1074/jbc.M106984200 Esfandiary, 2014, The evaluation of toxicity of carbon nanotubes on the human adipose-derived-stem cells in-vitro, Adv Biomed Res, 3, 40, 10.4103/2277-9175.125729 Kritharides, 1998, Cholesterol metabolism and efflux in human THP-1 macrophages, Arterioscler Thromb Vasc Biol, 18, 1589, 10.1161/01.ATV.18.10.1589 Hafiane, 2015, HDL-mediated cellular cholesterol efflux assay method, Ann Clin Lab Sci, 45, 659 Favari, 2004, Probucol inhibits ABCA1-mediated cellular lipid efflux, Arterioscler Thromb Vasc Biol, 24, 2345, 10.1161/01.ATV.0000148706.15947.8a Hassan, 2008, Quantitative analysis of ABCA1-dependent compartmentalization and trafficking of apolipoprotein A-I: implications for determining cellular kinetics of nascent high density lipoprotein biogenesis, J Biol Chem, 283, 11164, 10.1074/jbc.M707720200 Montermini, 2015, Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content, J Biol Chem, 290, 24534, 10.1074/jbc.M115.679217 Soo, 2012, Nanoparticle tracking analysis monitors microvesicle and exosome secretion from immune cells, Immunology, 136, 192, 10.1111/j.1365-2567.2012.03569.x Raposo, 2013, Extracellular vesicles: exosomes, microvesicles, and friends, J Cell Biol, 200, 373, 10.1083/jcb.201211138 Vaughan, 2006, ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL, J Lipid Res, 47, 2433, 10.1194/jlr.M600218-JLR200 Krimbou, 2005, Biogenesis and speciation of nascent apoA-I-containing particles in various cell lines, J Lipid Res, 46, 1668, 10.1194/jlr.M500038-JLR200 Ji, 2012, Nascent HDL formation in hepatocytes and role of ABCA1, ABCG1, and SR-BI, J Lipid Res, 53, 446, 10.1194/jlr.M017079 Vaughan, 2009, ABCA1 mutants reveal an interdependency between lipid export function, apoA-I binding activity, and Janus kinase 2 activation, J Lipid Res, 50, 285, 10.1194/jlr.M800366-JLR200 Yvan-Charvet, 2010, Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses, Arterioscler Thromb Vasc Biol, 30, 139, 10.1161/ATVBAHA.108.179283 Zheng, 2011, HDL mimetic peptide ATI-5261 forms an oligomeric assembly in solution that dissociates to monomers upon dilution, Biochemistry, 50, 4068, 10.1021/bi2002955 Hafiane, 2014, Apolipoprotein E derived HDL mimetic peptide ATI-5261 promotes nascent HDL formation and reverse cholesterol transport in vitro, Biochim Biophys Acta, 1842, 1498, 10.1016/j.bbalip.2014.07.018 Bielicki, 2015, Abstract 28: mechanistic studies of HDL mimetic peptide ATI-5261 reveal aspects of class A alpha-helix structure that induce cytotoxicity and hypertriglyceridemia in vivo: design of safe analogs with potent anti-atherosclerosis and anti-diabetic actions, Arterioscler Thromb Vasc Biol, 35, A28 Oram, 2000, ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins, CurrOpin Lipidol, 11, 253, 10.1097/00041433-200006000-00005 Hafiane, 2018, Extracellular vesicles characteristics and emerging roles in atherosclerotic cardiovascular disease, Metabolism, 85, 213, 10.1016/j.metabol.2018.04.008 Strauss, 2010, Exosome secretion ameliorates lysosomal storage of cholesterol in Niemann-Pick type C disease, J Biol Chem, 285, 26279, 10.1074/jbc.M110.134775 Nielsen, 2012, Circulating microparticles in systemic lupus erythematosus, Dan Med J, 59, B4548 Smith, 2010, Apolipoprotein A-I and its mimetics for the treatment of atherosclerosis, Curr Opin Investig Drugs, 11, 989